Cancer Epidemiology
About Cancer Epidemiology
Cancer epidemiology studies how often cancer occurs, who it affects and why. It tracks trends in incidence, survival and deaths, and identifies risk factors that can guide prevention and screening.
The Cancer Epidemiology session at Cancer Research 2027 brings together researchers working on cancer in populations. It connects closely with causes of cancer, which explores the factors behind cancer risk.
Epidemiology answers key questions such as how many people get cancer, who is most at risk and whether survival is improving. Cancer registries collect this information and make it available for research and planning. These numbers guide decisions on screening, prevention and health services. Without good data, it is hard to know whether cancer control efforts are working.
Key Topics in Cancer Epidemiology
• Cancer incidence and mortality trends
• Cancer registries and surveillance
• Survival and outcomes research
• Lifestyle and environmental risk factors
• Genetic and molecular epidemiology
• Cancer inequalities and social factors
• Screening programme evaluation
• Cancer in low- and middle-income countries
• Cancer burden in Asia
• Methods in cancer epidemiology
Recent Advances in Cancer Epidemiology
Large cohort studies and linked health records are giving clearer pictures of cancer risk and survival. Rising cancer rates in younger adults, especially bowel cancer, are a growing area of research.
Genetic epidemiology is helping identify people at high risk who could benefit from cancer prevention vaccines and targeted screening. AI methods from role of artificial intelligence in oncology are analysing large datasets, and links between cancer and conditions such as diabetes are explored in cancer and its relevance with other diseases.
Linked health records now allow researchers to follow large groups of people over many years. Studies are tracking new patterns, such as rising bowel cancer rates in younger adults. Researchers are also looking more closely at how income, location and ethnicity affect cancer risk and survival. These insights are helping target prevention where it is most needed.
Who Should Attend the Cancer Epidemiology Session
• Cancer epidemiologists and public health researchers
• Cancer registry staff
• Biostatisticians and data scientists
• Screening programme managers
• PhD students and early-career researchers
• Health policy makers
Why Present Your Research in Cancer Epidemiology
Presenting at Cancer Research 2027 puts your population research in front of clinicians and researchers worldwide. You can share findings and connect with colleagues in cancers by anatomical site who use epidemiology to guide care. Population data from your region can fill important gaps in the global picture. Your work can also help plan screening and services for the future.
Frequently Asked Questions
Can I present cancer registry data?
Yes. Registry and surveillance studies are welcome.
Does this session cover cancer inequalities?
Yes. Social and geographic inequalities in cancer are key topics.
Where is Cancer Research 2027 held?
Cancer Research 2027 is held at Village Hotel Changi, Singapore, from 8 to 10 March 2027, with an online option.